Sign in to continue:

Tuesday, July 28th, 2026

Forum Markets, Inc. Files 8-K Announcing Performance and Restricted Stock Unit Award Agreements – April 2026




Forum Markets, Inc. Files 8-K: New Equity Incentive Awards and Corporate Updates

Forum Markets, Inc. (NASDAQ: FRMM) Files 8-K: New Equity Incentive Awards and Corporate Updates

Key Highlights from the 8-K Filing

  • Equity Compensation Awards Announced: Forum Markets, Inc. has disclosed the approval and terms of new Performance Stock Unit (PSU) and Restricted Stock Unit (RSU) awards under its 2025 Omnibus Incentive Plan.
  • Potentially Price-Sensitive Information: The PSU awards are tied to significant “Share Price Hurdles,” directly incentivizing management to target higher share prices, which could align corporate performance with shareholder value.
  • Corporate History and Identity: The company has undergone several name changes in recent years, reflecting multiple strategic pivots, now operating as Forum Markets, Inc. and focusing on finance and crypto assets.
  • Regulatory Status: Forum Markets’ common stock is listed on NASDAQ under the symbol FRMM.
  • Company Status: Forum Markets, Inc. is NOT an Emerging Growth Company as per the SEC definition, and there are no current bankruptcy proceedings or shell company status.

Detailed Breakdown of Potentially Market-Moving Disclosures

1. Performance Stock Unit Award Agreement (Exhibit 10.1)

Forum Markets has granted Performance Stock Units (“PSUs”) to certain participants, as an incentive to drive long-term value creation. The key features of this award are:

  • Tranches and Vesting: The PSUs are divided into three tranches. Each tranche will vest only if BOTH a specific share price hurdle (“Share Price Hurdle”) and a service period (“Service Condition”) are achieved.
  • Share Price Hurdles:
    • Tranche 1: Vests if the company’s share price reaches at least \$[____] (exact figure not disclosed) for 30 trading days within any consecutive 60-day period, within five years of the grant date.
    • Tranche 2: Vests at a higher share price hurdle, also for 30/60 days, within the five-year window.
    • Tranche 3: Vests at the highest undisclosed hurdle, with the same time conditions.
  • Forfeiture: Any unachieved tranches at the end of five years will be forfeited.
  • Change in Control: If a “Change in Control” event occurs, all unachieved share price hurdles will be deemed achieved, likely resulting in accelerated vesting of all outstanding PSUs.
  • Termination of Employment: If a participant is terminated without cause before a change in control, only the tranches for which the price hurdles have been met will vest; others are forfeited.
  • Transfer Restrictions: PSUs are not assignable or transferable except under strict legal conditions.

Investor Note: The structure of these awards could be highly price-sensitive. If management has substantial incentives to increase the share price, this could lead to strategic moves, capital allocation, or corporate actions aimed at boosting market value. Additionally, any rumors or announcements relating to a merger, acquisition, or similar “Change in Control” could rapidly accelerate executive compensation and potentially affect dilution and share supply.

2. Restricted Stock Unit Award Agreement (Exhibit 10.2)

  • RSU Vesting: The RSUs are also granted in three tranches, each vesting on undisclosed future dates, subject to continued employment.
  • Standard Terms: Similar restrictions on transfer and forfeiture provisions apply.

Investor Note: While RSUs are standard, large grants or accelerated vesting could result in future dilution, which is an important factor for shareholders to monitor in subsequent proxy statements or 10-Q/K filings.

3. Company and Regulatory Information

  • Corporate Identity: Forum Markets, Inc. has previously operated as ETHZilla Corp, 180 Life Sciences Corp., and KBL Merger Corp. IV, indicating a history of strategic redirections.
  • Principal Office: 2875 South Ocean Blvd, Suite 200, Palm Beach, FL 33480.
  • SEC File Number: 001-38105.
  • Trading Symbol: FRMM; Exchange: NASDAQ.
  • Industry Focus: Finance services and crypto assets.

4. No Indication of Corporate Distress or Special Communications

  • No bankruptcy proceedings, no shell company status, and no written, soliciting, or tender offer communications flagged in this filing.
  • The company is not utilizing the emerging growth company extended accounting transition provisions.

Shareholder Considerations

  • The newly disclosed PSU and RSU awards are directly tied to future share price performance and service periods. This can significantly impact executive behavior and may lead to share price volatility if management pursues aggressive growth or corporate actions.
  • The “Change in Control” clause means any M&A activity, takeover approach, or strategic transaction could trigger accelerated vesting for management, potentially affecting dilution and governance.
  • Shareholders should closely monitor future filings for actual grant numbers, the specific share price hurdles, and any subsequent amendments or triggers.

Conclusion

The 8-K filing from Forum Markets, Inc. introduces potentially significant new equity compensation plans for management, tightly linking executive rewards to market performance and corporate transactions. While the exact price hurdles are not disclosed in this filing, the framework for future dilution and incentive-driven behavior is now public. Investors should pay close attention to future disclosures and any signs of strategic activity that might trigger vesting or change-in-control provisions.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full SEC filings and consult with financial advisors before making investment decisions. The company may update, amend, or provide additional disclosures in future filings that could alter the implications of the information summarized here.




View FORUM MARKETS Inc Historical chart here



BioNexus Gene Lab Calls for Malaysia–China Biotech Co-Development and Precision Healthcare Collaboration 1

BioNexus Gene Lab Corp. Pushes for Deeper Malaysia–China Bio...

AtlasClear Holdings, Inc. Files Form 8-K Announcing First Amendment to 2024 Equity Incentive Plan

AtlasClear Holdings, Inc. Announces Shareholder Approval of ...